Eli Lilly and Company (Lilly) is planning to invest an additional $450 million to increase the company’s production capacity at its Research Triangle Park facility in North Carolina. The proposed expansion is expected to help the American pharmaceutical company meet increased demand for its incretin products for diabetes and introduce the next generation of medicines. […]
Eli Lilly and Company (Lilly) said that it will invest more than $1 billion to build a new manufacturing plant in Concord, North Carolina. The new facility will be engaged in manufacturing parenteral (injectable) products and devices and boost the manufacturing capacity of the US pharma giant. It will generate close to 600 new jobs […]
German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio of Asklepios BioPharmaceutical features investigational pre-clinical and clinical stage candidates, which are being developed for the treatment of neuromuscular, cardiovascular, central nervous system, and metabolic diseases. Asklepios BioPharmaceutical was established […]
US pharma giant Eli Lilly and Company (Lilly) will build a new pharma manufacturing plant in North Carolina with an investment of more than $470 million for producing injectable products and delivery devices. The new Lilly pharma manufacturing facility will be built in Research Triangle Park, and will generate over 460 new jobs in Durham. […]